https://www.selleckchem.com/pr....oducts/blasticidin-s
18.3% overall had recurrent AD, all of whom had confirmation on imaging. Computed tomography was used to calculate BMI in 849 patients, of whom 470 (55.4%) were considered obese (BMI 3. The likelihood of recurrent AD was not significantly different in obese patients compared to their non-obese counterparts (P = 0.2473). CONCLUSION While obesity increases the risk of developing AD overall, it does not appear to increase the likelihood of developing recurrent AD. This has implications for risk stratification when consideri
Gefällt mir
Kommentar
Teilen
